# Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis

> **NCT04376970** · PHASE4 · COMPLETED · sponsor: **Military Hospital of Tunis** · enrollment: 51 (actual)

## Conditions studied

- Adenoviral Keratoconjunctivitis

## Interventions

- **DRUG:** FLUCON®
- **DRUG:** Cyclosporine A eye drops 0.5%

## Key facts

- **NCT ID:** NCT04376970
- **Lead sponsor:** Military Hospital of Tunis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04376970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04376970, "Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04376970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*